NO964431L - Ikke-spleisende varianter av gp350/220 - Google Patents
Ikke-spleisende varianter av gp350/220Info
- Publication number
- NO964431L NO964431L NO964431A NO964431A NO964431L NO 964431 L NO964431 L NO 964431L NO 964431 A NO964431 A NO 964431A NO 964431 A NO964431 A NO 964431A NO 964431 L NO964431 L NO 964431L
- Authority
- NO
- Norway
- Prior art keywords
- protein
- splicing variants
- sequences
- vectors
- proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Surgical Instruments (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22929194A | 1994-04-18 | 1994-04-18 | |
PCT/US1995/004611 WO1995028488A1 (en) | 1994-04-18 | 1995-04-13 | NON-SPLICING VARIANTS OF gp350/220 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO964431D0 NO964431D0 (no) | 1996-10-18 |
NO964431L true NO964431L (no) | 1996-12-11 |
NO319382B1 NO319382B1 (no) | 2005-07-25 |
Family
ID=22860582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19964431A NO319382B1 (no) | 1994-04-18 | 1996-10-18 | Isolert DNA-fragment som koder for EBV gp350-proteinet eller en forkortet versjon av dette, samt vektor, vertcelle og farmasoytisk sammensetning inneholdende DNA-fragmentet eller proteinet og fremgangsmate for fremstilling og anvendelse av disse |
Country Status (25)
Country | Link |
---|---|
US (3) | US6054130A (no) |
EP (1) | EP0769056B1 (no) |
JP (4) | JP3447743B2 (no) |
KR (1) | KR100380953B1 (no) |
CN (2) | CN100415895C (no) |
AT (1) | ATE210184T1 (no) |
AU (1) | AU707837B2 (no) |
BR (1) | BR9507473A (no) |
CA (1) | CA2187908C (no) |
CZ (1) | CZ292283B6 (no) |
DE (1) | DE69524415T2 (no) |
DK (1) | DK0769056T3 (no) |
ES (1) | ES2170144T3 (no) |
FI (2) | FI118224B (no) |
HU (1) | HU221647B1 (no) |
LV (1) | LV11803B (no) |
MY (1) | MY114769A (no) |
NO (1) | NO319382B1 (no) |
PL (1) | PL181881B1 (no) |
PT (1) | PT769056E (no) |
RU (1) | RU2178807C2 (no) |
SK (1) | SK283446B6 (no) |
TW (1) | TW496897B (no) |
UA (1) | UA47403C2 (no) |
WO (1) | WO1995028488A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6692749B1 (en) * | 1994-04-18 | 2004-02-17 | Medimmune Vaccines, Inc. | Non-splicing variants of gp350/220 |
MY114769A (en) | 1994-04-18 | 2003-01-31 | Aviron Inc | Non-splicing variants of gp350/220 |
AU2582897A (en) * | 1996-03-15 | 1997-10-01 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the diagnosis, prevention, and treatment of neoplastic cell growth and proliferation |
AUPO784197A0 (en) * | 1997-07-10 | 1997-08-07 | Csl Limited | Treatment of nasopharyngeal carcinoma |
AU735763B2 (en) * | 1997-12-05 | 2001-07-12 | Immune Response Corporation, The | Novel vectors and genes exhibiting increased expression |
CA2331258C (en) * | 1998-06-12 | 2011-09-20 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Enhancement of b cell activation and immunoglobulin secretion by co-stimulation of receptors for antigen and ebv gp350/220 |
GB0210682D0 (en) * | 2002-05-09 | 2002-06-19 | Glaxosmithkline Biolog Sa | Novel use |
US20100297612A1 (en) * | 2009-05-22 | 2010-11-25 | Intelligent Medical Devices, Inc. | Optimized probes and primers and methods of using same for the detection, screening, quantitation, isolation and sequencing of cytomegalovirus and epstein-barr virus |
US10461635B1 (en) * | 2018-05-15 | 2019-10-29 | Analog Devices Global Unlimited Company | Low VIN high efficiency chargepump |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0051079B1 (de) * | 1980-11-03 | 1984-09-26 | Deutsche ITT Industries GmbH | Binäres MOS-Ripple-Carry-Parallel-Addier/Subtrahierwerk und dafür geeignete Addier/Subtrahierstufe |
US4707358A (en) * | 1984-01-30 | 1987-11-17 | The University Of Chicago | Vaccine against Epstein-Barr Virus |
US5171568A (en) * | 1984-04-06 | 1992-12-15 | Chiron Corporation | Recombinant herpes simplex gb-gd vaccine |
US5244792A (en) * | 1984-04-06 | 1993-09-14 | Chiron Corporation | Expression of recombinant glyoprotein B from herpes simplex virus |
DE3583564D1 (de) * | 1984-08-23 | 1991-08-29 | Hans Joachim Wolf | Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten. |
EP0312164A1 (en) * | 1987-10-16 | 1989-04-19 | Merck & Co. Inc. | Purification of recombinant epstein-barr virus antigens from vero cells, yeast cells or L cells |
CA2090295A1 (en) * | 1992-02-03 | 1993-08-04 | Anthony B. Nesburn | Process for the expression of herpes simplex virus type 1 glycoprotein e and methods of use |
WO1993019092A1 (fr) * | 1992-03-19 | 1993-09-30 | Centre National De La Recherche Scientifique | Adenovirus recombinants defectifs exprimant des proteines caracteristiques du virus epstein-barr |
US5474914A (en) * | 1992-07-29 | 1995-12-12 | Chiron Corporation | Method of producing secreted CMV glycoprotein H |
MY114769A (en) | 1994-04-18 | 2003-01-31 | Aviron Inc | Non-splicing variants of gp350/220 |
-
1995
- 1995-04-06 MY MYPI95000884A patent/MY114769A/en unknown
- 1995-04-13 EP EP95916984A patent/EP0769056B1/en not_active Expired - Lifetime
- 1995-04-13 DK DK95916984T patent/DK0769056T3/da active
- 1995-04-13 SK SK1343-96A patent/SK283446B6/sk not_active IP Right Cessation
- 1995-04-13 UA UA96114355A patent/UA47403C2/uk unknown
- 1995-04-13 PT PT95916984T patent/PT769056E/pt unknown
- 1995-04-13 JP JP52710995A patent/JP3447743B2/ja not_active Expired - Lifetime
- 1995-04-13 HU HU9602894A patent/HU221647B1/hu not_active IP Right Cessation
- 1995-04-13 KR KR1019960705822A patent/KR100380953B1/ko not_active IP Right Cessation
- 1995-04-13 CN CNB031454984A patent/CN100415895C/zh not_active Expired - Lifetime
- 1995-04-13 CA CA002187908A patent/CA2187908C/en not_active Expired - Lifetime
- 1995-04-13 CZ CZ19963054A patent/CZ292283B6/cs not_active IP Right Cessation
- 1995-04-13 AT AT95916984T patent/ATE210184T1/de active
- 1995-04-13 DE DE69524415T patent/DE69524415T2/de not_active Expired - Lifetime
- 1995-04-13 ES ES95916984T patent/ES2170144T3/es not_active Expired - Lifetime
- 1995-04-13 RU RU96122169/13A patent/RU2178807C2/ru not_active IP Right Cessation
- 1995-04-13 AU AU23838/95A patent/AU707837B2/en not_active Expired
- 1995-04-13 BR BR9507473A patent/BR9507473A/pt not_active IP Right Cessation
- 1995-04-13 CN CN95193673A patent/CN1118573C/zh not_active Expired - Lifetime
- 1995-04-13 PL PL95316941A patent/PL181881B1/pl not_active IP Right Cessation
- 1995-04-13 WO PCT/US1995/004611 patent/WO1995028488A1/en active Application Filing
- 1995-09-13 TW TW084109561A patent/TW496897B/zh not_active IP Right Cessation
-
1996
- 1996-10-18 FI FI964186A patent/FI118224B/fi not_active IP Right Cessation
- 1996-10-18 NO NO19964431A patent/NO319382B1/no not_active IP Right Cessation
- 1996-11-12 LV LVP-96-430A patent/LV11803B/en unknown
-
1997
- 1997-01-15 US US08/783,774 patent/US6054130A/en not_active Expired - Lifetime
- 1997-08-25 US US08/917,320 patent/US5824508A/en not_active Expired - Lifetime
-
2000
- 2000-04-24 US US09/556,706 patent/US6458364B1/en not_active Expired - Lifetime
-
2003
- 2003-02-26 JP JP2003049908A patent/JP2003230396A/ja not_active Withdrawn
-
2004
- 2004-05-19 JP JP2004149099A patent/JP4317786B2/ja not_active Expired - Lifetime
-
2005
- 2005-06-15 JP JP2005175699A patent/JP2005333990A/ja active Pending
-
2007
- 2007-05-10 FI FI20075338A patent/FI20075338A/fi not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20075338A (fi) | gb350/220:n ei silmukoivia muutoksia | |
CA2263889A1 (en) | P-selectin ligand proteins | |
WO1989009787A3 (en) | Osteogenic devices | |
AU2058888A (en) | Variants of bovine pancreatic trypsin inhibitor produced by recombinant DNA technology, process, expression vector and recombinant host therefor and pharmaceutical use thereof | |
CA2161808A1 (en) | Bmp-11 compositions | |
IL115199A (en) | Composition comprising a polynucleic acid molecule in a liposome and method using said composition | |
HUT54213A (en) | Process for the enzymatic removal of n-terminal sequence of proteins | |
EP0875567A3 (de) | Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung | |
AU8258591A (en) | Human mk gene and protein sequence | |
PT1259536E (pt) | Métodos de preparação de péptidos | |
HU895788D0 (en) | Process for producing peptides and medical products containing them | |
WO1995030001A3 (en) | Novel p-selectin ligand protein | |
ATE374246T1 (de) | Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter | |
AU8811298A (en) | Novel peptides and polypeptides useful for regenerating the nervous system | |
AU3595489A (en) | Amblyommin, a new active substance for anticoagulant therapy | |
AU4034095A (en) | Cyclohexapeptides and their mixtures, a process for preparing them, and their use | |
CA2163805A1 (en) | Novel activating factor of leukocytes | |
EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
ATE224403T1 (de) | Verwendung von kaseinfragmenten als wachstumerförderer | |
CA2247998A1 (en) | Fragments of cr1 and their use | |
HUT37109A (en) | Process for the phosphinoylation of amino gropus of amino-acids, peptides and esters thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |